Brief: Medicamen Biotech Announces Strategic Expansion Into Regulated Markets
28/03/2025 09:01
March 28 (Reuters) - Medicamen Biotech Ltd MEBI.NS: MEDICAMEN BIOTECH LTD - ANNOUNCES STRATEGIC EXPANSION INTO REGULATED MARKETS MEDICAMEN BIOTECH LTD - OBTAINS EU AND USFDA APPROVALS FOR MANUFACTURING PLANTS Source text: ID:nNSE4R5B73 Further company coverage: MEBI.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma